Pope JE - Search Results

1

C-reactive protein and implications in rheumatoid arthritis and associated comorbidities.

Pope JE, Choy EH. Pope JE, et al. Semin Arthritis Rheum. 2021 Feb;51(1):219-229. doi: 10.1016/j.semarthrit.2020.11.005. Epub 2020 Dec 17. Semin Arthritis Rheum. 2021. PMID: 33385862 Free article. Review.

2

Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.

Hong P, Pope JE, Ouimet JM, Rullan E, Seibold JR. Hong P, et al. Among authors: pope je. J Rheumatol. 2004 Mar;31(3):508-13. J Rheumatol. 2004. PMID: 14994396

3

Osteoporosis in scleroderma.

Loucks J, Pope JE. Loucks J, et al. Among authors: pope je. Semin Arthritis Rheum. 2005 Feb;34(4):678-82. doi: 10.1016/j.semarthrit.2004.08.006. Semin Arthritis Rheum. 2005. PMID: 15692961 Review.

4

Campylobacter reactive arthritis: a systematic review.

Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. Pope JE, et al. Semin Arthritis Rheum. 2007 Aug;37(1):48-55. doi: 10.1016/j.semarthrit.2006.12.006. Epub 2007 Mar 13. Semin Arthritis Rheum. 2007. PMID: 17360026 Free PMC article. Review.

5

Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.

Yuen SY, Rochwerg B, Ouimet J, Pope JE. Yuen SY, et al. Among authors: pope je. J Rheumatol. 2008 Jun;35(6):1073-8. Epub 2008 Apr 15. J Rheumatol. 2008. PMID: 18412305

6

Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment.

Villela R, Yuen SY, Pope JE, Baron M; Canadian Scleroderma Research group. Villela R, et al. Among authors: pope je. Arthritis Rheum. 2008 May 15;59(5):706-13. doi: 10.1002/art.23567. Arthritis Rheum. 2008. PMID: 18438906 Free article.

7

Determinants of morbidity and mortality of systemic sclerosis in Canada.

Al-Dhaher FF, Pope JE, Ouimet JM. Al-Dhaher FF, et al. Among authors: pope je. Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15. Semin Arthritis Rheum. 2010. PMID: 18706680

8

The temporal relationship of Raynaud's phenomenon and features of connective tissue disease in rheumatoid arthritis.

Pope JE, Al-Bishri J, Al-Azem H, Ouimet JM. Pope JE, et al. J Rheumatol. 2008 Dec;35(12):2329-33. doi: 10.3899/jrheum.071025. Epub 2008 Oct 1. J Rheumatol. 2008. PMID: 18843783

9

Epidemiologic approaches to infection and immunity: the case of reactive arthritis.

Rohekar S, Pope J. Rohekar S, et al. Curr Opin Rheumatol. 2009 Jul;21(4):386-90. doi: 10.1097/BOR.0b013e32832aac66. Curr Opin Rheumatol. 2009. PMID: 19373091 Review.

10

Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.

Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A. Pease C, et al. Among authors: pope je. Semin Arthritis Rheum. 2011 Aug;41(1):81-9. doi: 10.1016/j.semarthrit.2010.09.004. Epub 2010 Dec 17. Semin Arthritis Rheum. 2011. PMID: 21168187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

479 results

Search Page